Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment
- PMID: 23960788
- PMCID: PMC3744933
- DOI: 10.1016/j.jsps.2011.10.001
Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment
Abstract
THE OBJECTIVE OF WORK WAS TO FORMULATE, EVALUATE AND COMPARE THE TRANSDERMAL POTENTIAL OF NOVEL VESICULAR NANOCARRIERS: ethosomes and ultradeformable liposomes, containing clotrimazole (CLT), an anti-fungal bioactive. The ethosomal formulation (ET4) and ultradeformable liposomal (UL) formulation (TT3) showed highest entrapment 68.73 ± 1.4% and 55.51 ± 1.7%, optimal nanometric size range 132 ± 9.5 nm and 121 ± 9.7 nm, and smallest polydispersity index 0.027 ± 0.011 and 0.067 ± 0.009, respectively. The formulation ET4 provided enhanced transdermal flux 56.25 ± 5.49 μg/cm(2)/h and decreased the lag time of 0.9 h in comparison to TT3 formulation (50.16 ± 3.84 μg/cm(2)/h; 1.0 h). Skin interaction and FT-IR studies revealed greater penetration enhancing effect of ET4 than TT3 formulation. ET4 formulation also had the highest zone of inhibition (34.6 ± 0.57 mm), in contrast to TT3 formulation (29.6 ± 0.57 mm) and marketed cream formulation (19.0 ± 1.00 mm) against candidal species. Results suggested ethosomes to be the most proficient carrier system for dermal and transdermal delivery of clotrimazole.
Keywords: Anticandidal efficiency; Atomic force microscopy; Ethosomes; Nanocarriers; Ultradeformable liposomes.
Figures








References
-
- Ahmed M.O., El-Gibaly I., Ahmed S.M. Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Int. J. Pharm. 1998;171:111–121.
-
- Bilensoy E., Rouf M.A., Vural I., Hincal A. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin. J. Contr. Rel. 2006;116:107–109. - PubMed
-
- Carrillo-Munoz A.J., Brio S., Alonso R., Valle O.D., Santos P., Quindos G. Ciclopiroxolamine: in-vitro antifungal activity against clinical yeast isolates. Int. J. Antimicrob. Agents. 2002;20:375–379. - PubMed
-
- Cevc G., Schatzlein A., Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented: Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta Biomembr. 2002;1564:21–30. - PubMed
-
- Dubey V., Mishra D., Asthana A., Jain N.K. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 2006;27:3491–3496. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials